This may be advantageous for the treatment of PAH, given that TASK-5 in conjunction with TASK-1, is one of the most highly expressed potassium channels in pulmonary vascular smooth muscle cells (VSMCs)16. The gene discussed is KCNK3; the disease is pulmonary arterial hypertension.